These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1111464)

  • 1. Treatment of myeloma. Comparison of melphalan, chlorambucil, and azathioprine.
    Arch Intern Med; 1975 Jan; 135(1):157-62. PubMed ID: 1111464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission maintenance therapy for multiple myeloma.
    Arch Intern Med; 1975 Jan; 135(1):147-52. PubMed ID: 1111463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myeloma.
    Cuttner J; Wasserman LR; Martz G; Sonntag RW; Kyle RA; Silver RT; Spurr C; Harley JB; Wiernik PM; Cornwell GG; Falkson G; Glidewell O; Holland JF
    Med Pediatr Oncol; 1975; 1(3):207-16. PubMed ID: 1232529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy of multiple myeloma. Review of the recent trials].
    Tribalto M; Arcese W; Colombo R; Pastore S; Franchii A
    Recenti Prog Med; 1981 Aug; 71(2):141-7. PubMed ID: 7031807
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone healing in multiple myeloma with melphalan chemotherapy.
    Rodriguez LH; Finkelstein JB; Shullenberger CC; Alexanian R
    Ann Intern Med; 1972 Apr; 76(4):551-6. PubMed ID: 4640313
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential therapy compared with combination therapy in multiple myeloma.
    Arch Intern Med; 1975 Jan; 135(1):163-71. PubMed ID: 1111465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two long-term chemotherapy regimens, with or without agents to modify skeletal repair, in multiple myeloma.
    Cohen HJ; Silberman HR; Tornyos K; Bartolucci AA
    Blood; 1984 Mar; 63(3):639-48. PubMed ID: 6421344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term low dose melphalan treatment of multiple myeloma.
    Brook J; Bateman JR; Gocka EF; Nakamura E; Steinfeld JL
    Arch Intern Med; 1973 Apr; 131(4):545-8. PubMed ID: 4699959
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rules of current therapy in multiple myeloma].
    Sonntag RW
    Schweiz Med Wochenschr; 1973 Sep; 103(38):1324-9. PubMed ID: 4763749
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy for multiple myeloma.
    Alexanian R; Salmon S; Bonnet J; Gehan E; Haut A; Weick J
    Cancer; 1977 Dec; 40(6):2765-71. PubMed ID: 589554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of plasma cell myeloma with cytotoxic agents.
    Bergsagel DE; Pruzanski W
    Arch Intern Med; 1975 Jan; 135(1):172-6. PubMed ID: 803363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ancillary measures in treatment of myeloma. Use of immune serum globulin, fluoride, or androgen.
    Schilling A; Finkel HE
    Arch Intern Med; 1975 Jan; 135(1):193-6. PubMed ID: 46143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy for multiple myeloma.
    Alexanian R; Bonnet J; Gehan E; Haut A; Hewlett J; Lane M; Monto R; Wilson H
    Cancer; 1972 Aug; 30(2):382-9. PubMed ID: 5051662
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medical treatment of multiple myeloma].
    Astaldi G; Meardi G; Yalçin B
    Cancro; 1973; 26(5):319-37. PubMed ID: 4793834
    [No Abstract]   [Full Text] [Related]  

  • 15. Melphalan and myeloma. Experience with a low-dose continuous regimen.
    McArthur JR; Athens JW; Wintrobe MM; Cartwright GE
    Ann Intern Med; 1970 May; 72(5):665-70. PubMed ID: 5448096
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple myeloma. II. The value of melphalan.
    Bernard DB; Lynch SR; Bothwell TH; Bezwoda WR; Stevens K; Shulman G
    S Afr Med J; 1974 May; 48(24):1026-8. PubMed ID: 4835772
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
    Case DC; Lee DJ; Clarkson BD
    Am J Med; 1977 Dec; 63(6):897-903. PubMed ID: 605911
    [No Abstract]   [Full Text] [Related]  

  • 18. Unmaintained remissions in multiple myeloma.
    Alexanian R; Gehan E; Haut A; Saiki J; Weick J
    Blood; 1978 Jun; 51(6):1005-11. PubMed ID: 647110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid therapy of multiple myeloma and macroglobulinemia.
    Hoogstraten B
    Med Clin North Am; 1973 Sep; 57(5):1321-30. PubMed ID: 4366516
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple myeloma resistant to melphalan: treatment with cyclophosphamide, prednisone, and BCNU.
    Kyle RA; Gailani S; Seligman BR; Blom J; McIntyre OR; Pajak TF; Holland JF
    Cancer Treat Rep; 1979 Aug; 63(8):1265-9. PubMed ID: 476704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.